* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Viet Nam Pharmaceutical - JSC's PEG Ratio or its related term are showing as below:
HSTC:DVN'
s PEG Ratio Range Over the Past 10 Years
Min: 0.28 Med: 0.83 Max: 1.07
Current: 0.28
During the past 7 years, Viet Nam Pharmaceutical - JSC's highest PEG Ratio was 1.07. The lowest was 0.28. And the median was 0.83.
HSTC:DVN's PEG Ratio is ranked better than 94.86% of 350
companies
in the Drug Manufacturers industry
Industry Median: 1.725
vs HSTC:DVN: 0.28
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Viet Nam Pharmaceutical - JSC (HSTC:DVN) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Viet Nam Pharmaceutical - JSC PEG Ratio Related Terms
Viet Nam Pharmaceutical - JSC PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Viet Nam Pharmaceutical - JSC's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Viet Nam Pharmaceutical - JSC PEG Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Viet Nam Pharmaceutical - JSC's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Viet Nam Pharmaceutical - JSC's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Viet Nam Pharmaceutical - JSC (HSTC:DVN) has a PEG Ratio of 0.28 as of Jul. 09, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Viet Nam Pharmaceutical - JSC and its competitors. This is 66% below median its historical median of 0.83. Over the past decade, Viet Nam Pharmaceutical - JSC's PEG Ratio has ranged from 0.28 to 1.07. According to the industry distribution chart, Viet Nam Pharmaceutical - JSC ranks #18 out of 350 companies in the Drug Manufacturers industry, placing it in the top 5.1%.
Is Viet Nam Pharmaceutical - JSC's PEG Ratio too high?
Viet Nam Pharmaceutical - JSC's current PEG Ratio of 0.28 is 66% below median its 10-year median of 0.83. Over the past 10 years, this metric has ranged from a low of 0.28 to a high of 1.07. The Drug Manufacturers industry median PEG Ratio is 1.73. Viet Nam Pharmaceutical - JSC's value of 0.28 is 83.8% below this industry median. Based on the distribution chart, Viet Nam Pharmaceutical - JSC ranks #18 out of 350 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Viet Nam Pharmaceutical - JSC has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Viet Nam Pharmaceutical - JSC's PEG Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Viet Nam Pharmaceutical - JSC ranks #18 out of 350 companies for PEG Ratio. This places Viet Nam Pharmaceutical - JSC in the top 5% of its industry — outperforming the majority of peers. The industry median PEG Ratio is 1.73. Viet Nam Pharmaceutical - JSC's value of 0.28 is 83.8% below this benchmark. Historically, Viet Nam Pharmaceutical - JSC's own PEG Ratio has ranged from 0.28 to 1.07 over the past decade. While the company's 10-year median is 0.83 vs. the industry median of 1.73, Viet Nam Pharmaceutical - JSC has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Drug Manufacturers company?
The median PEG Ratio among Drug Manufacturers companies is 1.73, based on 350 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Viet Nam Pharmaceutical - JSC's current PEG Ratio of 0.28 is 83.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Viet Nam Pharmaceutical - JSC and its competitors. For the Drug Manufacturers industry, the median PEG Ratio is 1.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Viet Nam Pharmaceutical - JSC's current PEG Ratio is 0.28, which is 66% below median its own 10-year median of 0.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viet Nam Pharmaceutical - JSC stock overvalued right now?
Based on GuruFocus' analysis, Viet Nam Pharmaceutical - JSC (HSTC:DVN) is currently considered Fairly Valued. The stock's GF Value™ is ₫22,074.26, compared to a current price of ₫20,000.00 — trading 9.4% below its estimated fair value. The current PEG Ratio is 0.28, which is 66% below median its 10-year median of 0.83 and 83.8% below the Drug Manufacturers industry median of 1.73. Viet Nam Pharmaceutical - JSC's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Viet Nam Pharmaceutical - JSC (HSTC:DVN), the current PEG Ratio is 0.28 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Viet Nam Pharmaceutical - JSC (HSTC:DVN) Overvalued in 2026?
Based on GuruFocus' analysis, Viet Nam Pharmaceutical - JSC stock appears to be undervalued.
The current stock price of ₫20,000.00 is trading 9.4% below its estimated GF Value™ of ₫22,074.26.
GuruFocus considers Viet Nam Pharmaceutical - JSC to be Fairly Valued.
Key valuation signals for HSTC:DVN:
PEG Ratio: 0.28 (66% below median its 10-year median of 0.83)
GF Value™: ₫22,074.26 vs. price of ₫20,000.00 (9.4% below fair value)
Industry Position: 83.8% below the Drug Manufacturers median (#18 of 350)
No single metric tells the full story. See the HSTC:DVN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Viet Nam Pharmaceutical - JSC Business Description
Viet Nam Pharmaceutical Corp - JSC is engaged in the manufacturing of drugs. The company provides testing services for drugs and medicinal ingredients.
79GF Score
Get the complete analysis for HSTC:DVN
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HSTC:DVN has been successfully added to your 
